Reports By Brokerage: Edelweiss
City Union Bank Research Report By Edelweiss | |
Company: | City Union Bank |
Brokerage: | Edelweiss |
Date of report: | December 23, 2020 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 42% |
Summary: | A bankable play! |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: Edelweiss
Pidilite: Buy Recommendation By Edelweiss | |
Company: | Pidilite |
Brokerage: | Edelweiss |
Date of report: | December 11, 2020 |
Type of Report: | Result Update |
Recommendation: | Buy |
Upside Potential: | 14.74% |
Summary: | Araldite buy: Perfect growth glue |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: Edelweiss
Glenmark Pharmaceuticals Ltd: Edelweiss Research Report | |
Company: | Glenmark Pharma |
Brokerage: | Edelweiss |
Date of report: | December 7, 2020 |
Type of Report: | Result Update |
Recommendation: | Buy |
Upside Potential: | 11% |
Summary: | API external sales were strong. As customers look to diversify away from China, expects the API business to continue to post strong growth |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: Edelweiss
Neogen Chemicals Ltd: Research Report By Edelweiss | |
Company: | Neogen Chemicals |
Brokerage: | Edelweiss |
Date of report: | December 3, 2020 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 22% |
Summary: | Transitioning into a CSM player |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: Edelweiss
Kalpataru Power Transmission Ltd Research Report By Edelweiss | |
Company: | Kalpataru Power Transmission Ltd |
Brokerage: | Edelweiss |
Date of report: | November 24, 2020 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 70% |
Summary: | Five factors that make it a compelling Tactical BUY |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: Edelweiss
5 Best Strong Pharma Stocks For Tactical Buy Now with strong catalysts (Edelweiss Research Report) | |
Company: | Model Portfolio |
Brokerage: | Edelweiss |
Date of report: | April 10, 2020 |
Type of Report: | Model Portfolio Sector Report |
Recommendation: | Buy |
Upside Potential: | 100% |
Summary: | 5 Bets for Tactical Buy |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: Edelweiss
Heritage Foods Ltd Research Report By Edelweiss | |
Company: | Heritage Foods |
Brokerage: | Edelweiss |
Date of report: | November 26, 2018 |
Type of Report: | Result Update |
Recommendation: | Buy |
Upside Potential: | 47% |
Summary: | Gearing towards being Future Ready…. |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: Edelweiss
5 Stocks To Buy For 53% Gain In 2018-19 | |
Company: | Aurobindo Pharma, Axis Bank, Firstsource Solutions Ltd, Muthoot Finance, PVR Ltd |
Brokerage: | Edelweiss |
Date of report: | November 13, 2018 |
Type of Report: | Model Portfolio |
Recommendation: | Buy |
Upside Potential: | 53% |
Summary: | Edelweiss Professional Investor Research |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: Edelweiss
Visaka Industries Ltd Initiating Coverage Research Report By Edelweiss | |
Company: | Visaka Industries |
Brokerage: | Edelweiss |
Date of report: | February 15, 2018 |
Type of Report: | Initiating Coverage |
Recommendation: | Buy |
Upside Potential: | 50% |
Summary: | Outlook and valuation: On a strong turf; initiate with ‘BUY’ |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |
Reports By Brokerage: Edelweiss
JK Paper Ltd Research Report By Edelweiss | |
Company: | JK Paper Ltd |
Brokerage: | Edelweiss |
Date of report: | May 16, 2018 |
Type of Report: | Result Update |
Recommendation: | Buy |
Upside Potential: | 41% |
Summary: | Strong Q4FY18 result; healthy B/S to support future capex plan |
Full Report: | Click here to view full post with link to download pdf file |
Tags: |